Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.

MLA

Niedźwiecki, Sebastian, et al. “Serum Levels of Interleukin-1 Receptor Antagonist (IL-1ra) in Thyroid Cancer Patients.” Langenbeck’s Archives of Surgery, vol. 393, no. 3, May 2008, pp. 275–80. EBSCOhost, https://doi.org/10.1007/s00423-007-0251-9.

APA

Niedźwiecki, S., Stepień, T., Kuzdak, K., Stepień, H., Krupiński, R., Seehofer, D., Rayes, N., & Ulrich, F. (2008). Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients. Langenbeck’s Archives of Surgery, 393(3), 275–280. https://doi.org/10.1007/s00423-007-0251-9

Chicago

Niedźwiecki, Sebastian, Tomasz Stepień, Krzysztof Kuzdak, Henryk Stepień, Roman Krupiński, Daniel Seehofer, Nada Rayes, and Frank Ulrich. 2008. “Serum Levels of Interleukin-1 Receptor Antagonist (IL-1ra) in Thyroid Cancer Patients.” Langenbeck’s Archives of Surgery 393 (3): 275–80. doi:10.1007/s00423-007-0251-9.